An omics-driven computational model for angiogenic protein prediction: Advancing therapeutic strategies with Ens-deep-AGP.

Angiogenic proteins (AGPs) play a critical role in both pathological and physiological activities, making them key therapeutic targets in diseases like cancer, heart disease, and stroke. Traditional methods for identifying AGPs are labor-intensive and time-consuming, creating a need for more efficient approaches. This study addresses this challenge by developing a novel computational model, Ens-Deep-AGP, designed to enhance AGP prediction. The model introduces innovative feature engineering techniques, including Position Specific Scoring Matrix-Decomposition-Discrete Cosine Transform (PSSM-DC-DCT) and Position Specific Scoring Matrix-Auto-Cross-Discrete Wavelet Transform (PSSM-ACC-DWT), which capture comprehensive protein sequence information. The ensemble feature set of these approaches are then fed into Multi-headed Ensemble Residual Convolutional Neural Network (MERCNN), a robust deep learning architecture. Ens-Deep-AGP achieved remarkable accuracy rates of 99.79 % on training dataset and 92.97 % on testing dataset, surpassing Convolutional Neural Networks (CNN), Gated Recurrent Units (GRU), and Bidirectional Long Short-Term Memory Networks (BiLSTM). The successful prediction of AGPs is crucial for accelerating drug development, discovering novel therapeutic targets and deepen our understanding of AGPs' complex roles in healthcare.
Competing Interests: Declaration of competing interest Authors have no competing interest.
(Copyright © 2024 Elsevier B.V. All rights reserved.)